8-K/A
Current Report
Damora Therapeutics, Inc. Filed Acc 0001193125-25-312912
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading glto-20251110.htm…